Find Clinical Trial

Long-term safety study of abexinostat (S 078454) per os given as single-agent in haematological malignancies – Extension study


← Back
Study Phase

Phase 1-2

Therapeutic Area

Cancers

Active Substance

ABEXINOSTAT, S078454

SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active Substance CodeS078454
Protocol CodeCL1-078454-018
EudraCT Code2014-002251-26


Documents and links

Results summary READ MORE




Quote

Results are not yet available.




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.
Accessibility